Editas Medicine, Inc. (EDIT)
2.55
-0.05
(-1.92%)
USD |
NASDAQ |
May 21, 09:32
Editas Medicine EPS Diluted (Quarterly) : -0.2552 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Puma Biotechnology, Inc. | -0.0738 |
| Black Diamond Therapeutics, Inc. | -0.1579 |
| X4 Pharmaceuticals, Inc. | -0.1603 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.98M |
| Revenue (Quarterly) | 2.831M |
| Total Expenses (Quarterly) | 27.81M |
| Enterprise Value | 202.88M |
| Gross Profit Margin (Quarterly) | 82.94% |
| Profit Margin (Quarterly) | -882.4% |
| Earnings Yield | -47.94% |
| Normalized Earnings Yield | -41.22 |